Sartorius | SRT3 - 销售收入

金融业

EUR

EUR 9.87B

现金及等价物

EUR 573.8M

EUR 484.6M

EUR 1.92B

EUR 2.11B

EUR 4.28B

股息收益率

0.35

EUR 160.7M

EUR 267.3M

15.94K

EPS每股收益

EUR 1.2

股本和储备

EUR 2.73B

EUR 414.5M

债务利息支出

EUR 49.5M

EUR -31.8M

EUR 3.34B

EUR 8.16B

EUR 56.2M

EUR 738.4M

EUR 160.7M

普通股股本

EUR 69.05M

43.44

EUR 157.8M

EUR 899.1M

销售和管理费用

EUR 221.3M

EUR 827.1M

贸易债权人

EUR 345.3M

应收帐款人

EUR 366.6M

	销售	更改		日
Akebia Therapeutics	USD 57.62M		1.14M	2025-12
Alaunos Therapeutics	USD 2K		2K	2025-03
Avita Medical	AUD 17.61M		805K	2025-12
Dianthus Therapeutics	USD 463K		179K	2026-03
Ionis Pharmaceuticals	USD 246M		43M	2026-03
IQVIA Holdings	USD 4.15B		210M	2026-03
Moderna	USD 389M		289M	2026-03
Organon & Co	USD 1.46B		50M	2026-03
Revvity	USD 711M		61.06M	2026-03
Sartorius	EUR 899.1M		28.5M	2026-03
Tectonic Therapeutic	USD 0		0	2024-12
Viatris	USD 3.52B		180M	2026-03
Xeris Pharmaceuticals	USD 83.13M		2.68M	2026-03